Fortis Healthcare Ltd

Fortis Healthcare Ltd

Fortis Healthcare Ltd has issued a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, certifying the details of securities dematerialized/rematerialized during the period.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced that its wholly owned subsidiary, Fortis Hospotel Limited, will acquire 26% equity shares of Clean Max Sau Private Limited, a special purpose vehicle (SPV) set up for a captive solar power generation project in Haryana. The acquisition is valued at up to Rs. 1.85 crore and is expected to be completed within 3 months.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has made a compliance filing with the National Stock Exchange and BSE, disclosing details of its listed debt securities as on September 30, 2026, in accordance with SEBI's Master Circular.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced that the Supreme Court of India has disposed of the Special Leave Petition filed by Fortis challenging the Delhi High Court's order requiring a forensic audit. IHH Healthcare Berhad, the parent company of Fortis, has stated that its investment in Fortis was made through a transparent and regulated process and that it will cooperate with the forensic audit.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has received a clarification from the Hon'ble Supreme Court on a Special Leave Petition filed by the company, which had challenged an order passed by the Hon'ble Delhi High Court. The Supreme Court has allowed a forensic audit to proceed, while clarifying that certain observations made by the High Court shall not influence the conduct or outcome of the audit. The Company remains committed to the highest standards of corporate governance, transparency, and regulatory compliance.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter and half year ended September 30, 2026.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced that Northern TK Venture Pte Ltd, an indirect wholly owned subsidiary of IHH Healthcare, has filed a petition for appeal against the judgment issued by the Tokyo District Court with the Tokyo High Court.

Fortis Healthcare Ltd

Fortis Healthcare Limited has signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services to a 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. The hospital is expected to commence operations in 3-4 years, subject to necessary approvals.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services to a 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. The hospital will be owned, operated, and managed by the SLJ Society, with Fortis providing healthcare services under a 29-year agreement.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced the schedule of upcoming Investors Meetings with the Management to discuss general business update and industry insights.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced the schedule of upcoming Investors Meetings with the Management to discuss general business update and industry insights.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced a revised intimation for an investor meet with IHH Healthcare Berhad to discuss general business updates and the industry. The meet will be held on September 14-15, 2026, in London.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced a revised intimation for an investor meet with IHH Healthcare Berhad to discuss general business updates and the industry. The meet will be held on September 14-15, 2026, in London.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced an investor meet with management to discuss general business update and industry trends. The meet will be held in London on September 14-15, 2026, and will not include any unpublished price sensitive information.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced an investor meet schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meet will be held in London on September 14-15, 2026, to discuss the company's general business update and industry trends.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced an investor meet with management to provide an update on recent developments. The meet is scheduled for September 4, 2026, and will be held virtually. No unpublished price sensitive information will be shared or discussed during the meet.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has received an order from the Delhi High Court directing a forensic audit into the dissipation of the shareholding of its erstwhile promoters, the Singh Brothers, and the subsequent change in control of the company. The court has not imposed any liability or penalty on the company, which was not a party to the original dispute.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has received an ESG Rating for the financial year 2025-26 from Crisil ESG Ratings & Analytics Ltd, with a rating of 'Crisil ESG 66' and 'Crisil Core ESG 72' in the 'Strong' category.

Fortis Healthcare Ltd

Fortis Healthcare Ltd reported Q1 FY27 earnings with consolidated revenue of INR 2,545 crores, a 17.5% growth over Q1 FY26. Hospital business revenues grew 19% to INR 2,187 crores, while diagnostic business gross revenue grew 10.2% to INR 407 crores. Consolidated operating EBITDA pre-ESOP expenses increased 15.8% to INR 568 crores, with a margin of 22.3%. Net debt stands at INR 2,233 crores with a net debt-to-EBITDA ratio of 1.01x.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has submitted the voting results and consolidated Scrutinizer Report for its 30th Annual General Meeting held on August 11, 2026, through video conferencing.